Age

60–any

Sex

MALE

Healthy volunteers

Not accepted

Male aged ≥60 years
Localized prostate cancer of low or intermediate risk (T1-T2)
Gleason score 6-7
PSA \<15 ng/mL
No evidence of metastatic disease
Radiotherapy indicated for prostate cancer
Affiliated with or benefiting from a French social security system
French-speaking patient
Patient appropriately informed and having signed a written informed consent form

Unable to read, write, or understand French
Vulnerable patient as defined by Article L1121-6 of the French Public Health Code
Adult under guardianship, curatorship, or legal protection ("sauvegarde de justice")
Patient unable to personally provide informed consent according to Article L1121-8 of the French Public Health Code
Patient already included in another interventional study that could interfere with study outcomes
History of urological (prostate) or digestive surgery that could influence study outcomes
Refusal to sign the written informed consent form

Adaptive Stereotactic Radiotherapy for Localized Prostate Cancer